Schizophrenia Trial, Recruiting NCT05748990 Sponsor: Centre for Addiction and Mental Health Condition: Schizophrenia
Back to Schizophrenia

Schizophrenia Trial, Recruiting

NCT05748990
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with a schizophrenia spectrum disorder (experimental group):

  • People aged 17 to 45 years
  • People of any sex
  • People who have been diagnosed for the first time with one of the following conditions: schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, brief psychotic disorder, a psychotic disorder not otherwise specified, major depressive disorder with psychotic symptoms, bipolar I or II disorder, or substance-induced psychosis — and who are receiving antipsychotic medication for one of these conditions (diagnosis will be confirmed through medical records)
  • People with a Body Mass Index (BMI) of 27 or below (BMI is a measure based on height and weight)

For healthy volunteers (control group):

  • People aged 17 to 45 years
  • People whose sex, dominant hand, and BMI are matched to a participant in the experimental group
  • People who do not have any condition listed in the DSM-5 diagnostic manual, other than a specific phobia (a fear of a particular thing or situation)

Who may not be able to join:

  • People with moderate or severe substance use disorder (the trial team will use their judgment in cases of moderate alcohol or cannabis use)
  • People who have prediabetes, diabetes, or signs of difficulty processing blood sugar, identified through a glucose tolerance test at screening
  • People who are currently at acute risk of suicide
  • People who are currently taking medications for weight management, cholesterol, diabetes, or blood pressure
  • People with liver or kidney disease
  • People who are pregnant
  • People who are currently breastfeeding
  • People who have a pacemaker
  • People who have a metallic heart valve
  • People who have magnetic materials in their body, such as surgical clips or implanted electronic pumps, or any other condition that would make an MRI scan unsafe
  • People with significant claustrophobia (fear of enclosed spaces), as determined by the MRI screening form and the study team's assessment
  • People with a history of a head injury that caused loss of consciousness for more than 30 minutes and required medical treatment
  • People whose head or neck size would prevent them from fitting in the MRI or PET scanning equipment
  • People who weigh more than 350 pounds (the weight limit for the MRI scanner bed)
  • People with an unstable physical health condition
  • People with a significant neurological condition, including epilepsy or a seizure disorder
  • People who have already received the maximum allowed radiation dose of 20 mSv in the past 12 months
  • People who have had more than 6 PET scans in their lifetime, if participating in this study would bring their total above 8 PET scans lifetime (the limit set by the Centre for Addiction and Mental Health Brain Health Imaging Centre)
  • People with a clinically significant abnormality noted in their medical history (confirm with trial site)
  • People currently taking any medication that could interfere with the study or affect the results of PET imaging (for example, anti-diabetic medications)
  • People with blood clotting disorders or who are currently taking blood-thinning medications

Additional exclusion for healthy volunteers only:

  • People who have a parent, sibling, or child with a primary psychotic disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-535-8501

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre for Addiction and Mental Health
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
1 August 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

[18F]-FDG brain uptake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov